Filing Details
- Accession Number:
- 0001209191-22-025515
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-25 16:11:06
- Reporting Period:
- 2022-04-21
- Accepted Time:
- 2022-04-25 16:11:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 651311552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586893 | Scott J Wolchko | C/O Fate Therapeutics, Inc. 12278 Scripps Summit Drive San Diego CA 92131 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-21 | 30,000 | $2.70 | 461,546 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-21 | 22,715 | $34.57 | 438,831 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-21 | 4,062 | $35.73 | 434,769 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-21 | 2,220 | $36.70 | 432,549 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-21 | 1,003 | $37.90 | 431,546 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-22 | 10,000 | $2.70 | 441,546 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-22 | 9,162 | $34.54 | 432,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-22 | 838 | $35.15 | 431,546 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-21 | 30,000 | $2.70 | 30,000 | $2.70 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-22 | 10,000 | $2.70 | 10,000 | $2.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 46,246 | 2027-01-03 | No | 4 | M | Direct | |
| 36,246 | 2027-01-03 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
- Represents the weighted average sale price of the shares sold from $34.22 to $35.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7.
- Represents the weighted average sale price of the shares sold from $35.29 to $36.25 per share.
- Represents the weighted average sale price of the shares sold from $36.29 to $37.08 per share.
- Represents the weighted average sale price of the shares sold from $37.70 to $38.38 per share.
- Represents the weighted average sale price of the shares sold from $34.04 to $35.03 per share.
- Represents the weighted average sale price of the shares sold from $35.04 to $35.29 per share.
- This option is fully vested.
Billionaire Hedge Funds
